{{I'm probably stating the obvious but I believe that the more personalized we get with cancer, the better success rates we see in both drug development and treatment outcome. }}
Yes, but the market size for a drug may decline as it will only be prescribed in patient populations where the genetic profile increases chance for a positive effect.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.